Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TICRR | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | CDC25A | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | HS3ST4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | VKORC1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | RBKS | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | PPM1G | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | COMMD7 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | CENPC | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | FAM72D | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | MCMBP | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |